Will Strong Utilities Demand Drive Primoris Services' EPS Higher? — Positive

PRIM   Zacks Investment Research — August 22, 2025

PRIM rides strong utilities demand, margin gains and data center prospects to fuel EPS growth in 2025.

image for news Will Strong Utilities Demand Drive Primoris Services' EPS Higher?

Big Tech Woes Power Surge in Inverse Single-Stock ETFs — Negative

CONI  PLTZ   Zacks Investment Research — August 22, 2025

PLTZ, SMST, IONZ, CONI and SMCZ witness double-digit gains as the S&P 500 logged its longest losing streak of 2025 on tech-driven weakness.

image for news Big Tech Woes Power Surge in Inverse Single-Stock ETFs

Is ConocoPhillips a Bullish Bet Despite Volatile Oil Prices? — Positive

COP   Zacks Investment Research — August 22, 2025

COP's low-cost global portfolio helps it stay resilient and generate cash flow even in a challenging oil price environment.

image for news Is ConocoPhillips a Bullish Bet Despite Volatile Oil Prices?

Best Momentum Stock to Buy for August 22nd — Positive

AM  JXN  TLN   Zacks Investment Research — August 22, 2025

AM, BZ and TLN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 22, 2025.

image for news Best Momentum Stock to Buy for August 22nd

Earnings Preview: BRP Inc. (DOOO) Q2 Earnings Expected to Decline — Negative

DOOO   Zacks Investment Research — August 22, 2025

BRP (DOOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: BRP Inc. (DOOO) Q2 Earnings Expected to Decline

CoreWeave to Deploy NVIDIA Spectrum-XGS Ethernet With Scale-Across Technology CoreWeave to Deploy NVIDIA Spectrum-XGS Ethernet With Scale-Across Technology

image for news NVIDIA Introduces Spectrum-XGS Ethernet to Connect Distributed Data Centers Into Giga-Scale AI Super-Factories

MORTON GROVE, Ill. , Aug. 22, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) (Lifeway or The Company), a leading supplier of kefir and fermented probiotic products to support the microbiome, today announced the comeback of its Basics Plus™ line of kefir and colostrum supplement shots, a product that first debuted nearly three decades ago.

image for news Lifeway Foods Relaunches Basics Plus™ Line of Kefir and Colostrum Shots, Reviving a Functional Food Innovation 30 Years Ahead of Its Time

JACKSONVILLE, Fla. and FORT WORTH, Texas, Aug. 22, 2025 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ:CSX) (CSX) and BNSF today announced several new intermodal service products that will offer customers seamless, efficient, coast-to-coast solutions to ship between the western and eastern U.S.

image for news CSX, BNSF announce new intermodal services, offering seamless coast-to-coast rail solutions

Kimbal Musk, Elon Musk's younger brother, said the Tesla CEO "deserves to be paid." Tesla earlier this month granted Elon Musk an interim pay package worth $29 billion.

image for news Kimbal Musk on Elon's Tesla pay package: 'My brother deserves to be paid'

Zoom Communications Stock Jumps on Q2 Beat-and-Raise — Positive

ZM   Schaeffers Research — August 22, 2025

Zoom Communications Inc (NASDAQ:ZM) stock is surging today, last seen up 10.3% at $80.69, after the video conferencing name posted better-than-expected second-quarter results and lifted its full-year revenue and profit forecasts, citing AI utilization.

image for news Zoom Communications Stock Jumps on Q2 Beat-and-Raise

NVIDIA Likely to Beat Q2 Earnings Estimate: How to Play the Stock? — Positive

NVDA   Zacks Investment Research — August 22, 2025

NVDA is poised to beat on Q2 earnings as surging AI, data center and gaming demand might have driven massive revenue and earnings growth.

image for news NVIDIA Likely to Beat Q2 Earnings Estimate: How to Play the Stock?

Stryker's Robotics and Global Gains Offset by Macro Concerns — Positive

SYK   Zacks Investment Research — August 22, 2025

SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.

image for news Stryker's Robotics and Global Gains Offset by Macro Concerns

NVIDIA's Data Center Grows Fast: Can It Sustain the Momentum? — Positive

NVDA   Zacks Investment Research — August 22, 2025

AI demand, Blackwell chips and expanding hyperscaler orders are likely to continue driving NVDA's Data Center revenues.

image for news NVIDIA's Data Center Grows Fast: Can It Sustain the Momentum?

Strong Cash Flow Keeps ExxonMobil Ahead in a Volatile Energy Market — Neutral

XOM   Zacks Investment Research — August 22, 2025

XOM's $5.4B free cash flow in Q2 underscores its financial strength, fueling returns, investments and resilience in volatile energy markets.

image for news Strong Cash Flow Keeps ExxonMobil Ahead in a Volatile Energy Market

PPL vs. FirstEnergy: Which Utility Stock Powers Up Stronger Returns? — Positive

FE  PPL   Zacks Investment Research — August 22, 2025

Both PPL and FE are regulated electric utilities and investing in infrastructure improvements to cater the rising demand from data centers.

image for news PPL vs. FirstEnergy: Which Utility Stock Powers Up Stronger Returns?

Insulet Gains 77.2% in a Year: What's Driving the Rally? — Positive

PODD   Zacks Investment Research — August 22, 2025

PODD's 77.2% stock surge is fueled by Omnipod 5 expansion, global launches, strong Q2 profits and robust financial stability.

image for news Insulet Gains 77.2% in a Year: What's Driving the Rally?

Should Boston Scientific Stock Be in Your Portfolio Right Now? — Positive

BSX   Zacks Investment Research — August 22, 2025

BSX's global expansion and MedSurg growth boost Q2 momentum, though currency and macro headwinds weigh on the same.

image for news Should Boston Scientific Stock Be in Your Portfolio Right Now?

GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo — Negative

GILD   Zacks Investment Research — August 22, 2025

Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with Interius BioTherapeutics.

image for news GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo

Shell Teams Up to Boost FPSO Safety Using AI and Data Analysis — Positive

SHEL   Zacks Investment Research — August 22, 2025

SHEL teams with Modec, Unicamp and Shape Digital to use AI and data analysis to enhance safety and reduce risks on FPSO offshore vessels.

image for news Shell Teams Up to Boost FPSO Safety Using AI and Data Analysis

The average of price targets set by Wall Street analysts indicates a potential upside of 248.8% in Mersana Therapeutics (MRSN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet